Ken‐ichi Akamatsu

Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways

Junya Fujita, Toshimasa Tsujinaka, Masahiko Jano et al. · International Journal of Cancer · 1996 · 137 citations · Full text

Medicine, Immunology, Oncology +13

ANTI-INTERLEUKIN 6 (IL-6) RECEPTOR ANTIBODY SUPPRESSES CASTLEMAN'S DISEASE LIKE SYMPTOMS EMERGED IN IL-6 TRANSGENIC MICE

Asao Katsume, Hiroyuki Saito, Yoshiki Yamada et al. · Cytokine · 2002 · 133 citations

Life Sciences, Immunology, Pathology +13

Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.

Yasuo Mizutani, Benjamin Bonavida, Yasuo Koishihara et al. · PubMed · 1995 · 127 citations

Medicine, Oncology, Pharmacology +17

Isothiazolone Derivatives Selectively Inhibit Telomerase from Human and Rat Cancer Cells <i>in Vitro</i>

Nobuki Hayakawa, Katsura Nozawa, Akio Ogawa et al. · Biochemistry · 1999 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Down-regulation of Telomerase Activity Is an Early Event in the Differentiation of HL60 Cells

Ericka Savoysky, Kenji Yoshida, Toshihiko Ohtomo et al. · Biochemical and Biophysical Research Communications · 1996 · 82 citations

Life Sciences, Cell Biology, Molecular Biology +11